High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus

被引:23
|
作者
San-Juan, Rafael [1 ]
Viedma, Esther [1 ]
Chaves, Fernando [1 ]
Lalueza, Antonio [1 ]
Fortun, Jesus [2 ]
Loza, Elena [2 ]
Pujol, Miguel [3 ]
Ardanuy, Carmen [3 ]
Morales, Isabel [4 ]
de Cueto, Marina [4 ]
Resino-Foz, Elena [1 ]
Morales-Cartagena, Alejandra [1 ]
Rico, Alicia [5 ]
Romero, Maria P. [5 ]
Angeles Oreliana, Maria [1 ]
Lopez-Medrano, Francisco [1 ]
Fernandez-Ruiz, Mario [1 ]
Maria Aguado, Jose [1 ]
机构
[1] Univ Hosp, Res Inst 12 Octubre, Madrid, Spain
[2] Hosp Univ Ramon y Cajal, Madrid, Spain
[3] Univ Hosp Bellvitge, Inst Biomed Res, Barcelona, Spain
[4] Hosp Univ Virgen de la Macarena, Seville, Spain
[5] Hosp Univ La Paz, Madrid, Spain
关键词
MINIMUM INHIBITORY CONCENTRATION; REDUCED SUSCEPTIBILITY; BACTERICIDAL ACTIVITY; BACTEREMIA; INTERMEDIATE; ENDOCARDITIS; PREDICT; COMBINATION; RESISTANCE; HOSPITALS;
D O I
10.3201/eid2206.151709
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011 June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 mu g/mL and 0.5 mu g/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications.
引用
收藏
页码:1057 / 1066
页数:10
相关论文
共 50 条
  • [21] Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
    Hu, Jian
    Ma, Xiao Xue
    Tian, Yuan
    Pang, Long
    Cui, Long Zhu
    Shang, Hong
    PLOS ONE, 2013, 8 (09):
  • [22] Predicting High Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
    Lubin, Andrew S.
    Snydman, David R.
    Ruthazer, Robin
    Bide, Pralhad
    Golan, Yoav
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (08) : 997 - 1002
  • [23] Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis
    Adamu, Yau
    Puig-Asensio, Mireia
    Dabo, Bashir
    Schweizer, Marin L.
    PLOS ONE, 2024, 19 (02):
  • [24] Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection
    Meije, Yolanda
    Almirante, Benito
    Luis Del Pozo, Jose
    Teresa Martin, Maria
    Fernandez-Hidalgo, Nuria
    Shan, Adriana
    Basas, Jana
    Pahissa, Albert
    Gavalda, Joan
    JOURNAL OF INFECTION, 2014, 68 (06) : 548 - 552
  • [25] Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections
    Schweizer, Marin L.
    Richardson, Kelly
    Sarrazin, Mary S. Vaughan
    Goto, Michihiko
    Livorsi, Daniel J.
    Nair, Rajeshwari
    Alexander, Bruce
    Beck, Brice F.
    Jones, Michael P.
    Puig-Asensio, Mireia
    Suh, Daniel
    Ohl, Madeline
    Perencevich, Eli N.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 : S68 - S73
  • [26] Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?
    Lodise, Thomas P.
    Drusano, George L.
    Zasowski, Evan
    Dihmess, Amanda
    Lazariu, Victoria
    Cosler, Leon
    McNutt, Louise-Anne
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (05) : 666 - 675
  • [27] Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis
    Maraolo, Alberto Enrico
    Giaccone, Agnese
    Gentile, Ivan
    Saracino, Annalisa
    Bavaro, Davide Fiore
    ANTIBIOTICS-BASEL, 2021, 10 (08):
  • [28] Early High-Dose Daptomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections With Elevated Vancomycin Minimum Inhibitory Concentrations: Ready for Prime Time?
    Weston, Adam
    Boucher, Helen W.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1570 - 1572
  • [29] Use of Daptomycin to Treat Infections With Methicillin-Resistant Staphylococcus aureus Isolates Having Vancomycin Minimum Inhibitory Concentrations of 1.5 to 2 μg/mL
    McDaneld, Patrick M.
    Spooner, Linda M.
    Mohr, John F.
    Belliveau, Paul P.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (12) : 1654 - 1665
  • [30] Evaluation of in vitro susceptibility trends to vancomycin and daptomycin by strain type of Staphylococcus aureus causing bloodstream infections
    Shoyinka, Adenike
    Moreno, Daniela
    Arshad, Samia
    Perri, Mary B.
    Donabedian, Susan M.
    Jacobsen, Gordon
    Hartman, Pamela
    Ziegler, Rachel
    Huang, Vanthida
    Zervos, Marcus J.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (04) : 280 - 285